Literature DB >> 20628065

Role of immune-regulatory cells in skin pathology.

Dan Ilkovitch1.   

Abstract

The skin harbors a complex and unique immune system that protects against various pathologies, such as infection and cancer. Although many of the mechanisms of immune activation in the skin have been investigated, it is likewise important to uncover the immune-regulatory components that limit effective immunity or prevent autoimmunity. Several cell populations are involved in this immune-regulatory function, including CD4+ T cells that coexpress the transcription factor Foxp3, known as Tregs, and cells with immune-regulatory function known as myeloid-derived suppressor cells (MDSCs). This review focuses on the role that immune-regulatory cells, such as MDSCs and Tregs, play in cutaneous pathology, such as malignancy, psoriasis, dermatitis, burn wounds, and transplantation. Although their depletion may serve to augment immunity, expansion of these cells may be used to suppress excessive immune reactions. These cells are attractive, therapeutic targets for various conditions and thus, deserve further exploration.

Entities:  

Mesh:

Year:  2010        PMID: 20628065      PMCID: PMC3004521          DOI: 10.1189/jlb.0410229

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  134 in total

1.  Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation.

Authors:  Hideaki Sugiyama; Rolland Gyulai; Eiko Toichi; Edina Garaczi; Shinji Shimada; Seth R Stevens; Thomas S McCormick; Kevin D Cooper
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

Review 2.  Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis.

Authors:  Cristina Albanesi; Claudia Scarponi; Daniela Bosisio; Silvano Sozzani; Giampiero Girolomoni
Journal:  Autoimmunity       Date:  2010-04       Impact factor: 2.815

3.  Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.

Authors:  Paola Filipazzi; Roberta Valenti; Veronica Huber; Lorenzo Pilla; Paola Canese; Manuela Iero; Chiara Castelli; Luigi Mariani; Giorgio Parmiani; Licia Rivoltini
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

4.  The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats.

Authors:  Li-Feng Huang; Yong-Ming Yao; Li-Tian Zhang; Ning Dong; Yan Yu; Zhi-Yong Sheng
Journal:  Shock       Date:  2009-03       Impact factor: 3.454

5.  In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.

Authors:  Hiroshi Nagai; Tatsuya Horikawa; Isao Hara; Atsushi Fukunaga; Shuntaro Oniki; Masahiro Oka; Chikako Nishigori; Masamitsu Ichihashi
Journal:  Exp Dermatol       Date:  2004-10       Impact factor: 3.960

6.  Development of dermatitis in CD18-deficient PL/J mice is not dependent on bacterial flora, and requires both CD4+ and CD8+ T lymphocytes.

Authors:  Shayne C Barlow; Hui Xu; Casey T Weaver; J Russell Lindsey; Trenton R Schoeb; Daniel C Bullard
Journal:  Int Immunol       Date:  2004-02       Impact factor: 4.823

7.  High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.

Authors:  Paolo Serafini; Rebecca Carbley; Kimberly A Noonan; Gladys Tan; Vincenzo Bronte; Ivan Borrello
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

8.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Authors:  C Marcela Diaz-Montero; Mohamed Labib Salem; Michael I Nishimura; Elizabeth Garrett-Mayer; David J Cole; Alberto J Montero
Journal:  Cancer Immunol Immunother       Date:  2008-04-30       Impact factor: 6.968

9.  Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma.

Authors:  Sergei Kusmartsev; Zhen Su; Axel Heiser; Jens Dannull; Evgeniy Eruslanov; Hubert Kübler; Donna Yancey; Philip Dahm; Johannes Vieweg
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

10.  IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis.

Authors:  Jason R Chan; Wendy Blumenschein; Erin Murphy; Caroline Diveu; Maria Wiekowski; Susan Abbondanzo; Linda Lucian; Richard Geissler; Scott Brodie; Alexa B Kimball; Daniel M Gorman; Kathleen Smith; Rene de Waal Malefyt; Robert A Kastelein; Terrill K McClanahan; Edward P Bowman
Journal:  J Exp Med       Date:  2006-10-30       Impact factor: 14.307

View more
  4 in total

1.  LED phototherapy in full-thickness burns induced by CO2 laser in rats skin.

Authors:  Milene da Silva Melo; Leandro Procópio Alves; Adriana Barrinha Fernandes; Henrique Cunha Carvalho; Carlos José de Lima; Egberto Munin; Mônica Fernandes Gomes; Miguel Angel Castillo Salgado; Renato Amaro Zângaro
Journal:  Lasers Med Sci       Date:  2018-04-27       Impact factor: 3.161

2.  Targeted deletion of RasGRP1 impairs skin tumorigenesis.

Authors:  Amrish Sharma; Lauren L Fonseca; Cynthia Rajani; Jodi K Yanagida; Yuka Endo; J Mark Cline; James C Stone; Junfang Ji; Joe W Ramos; Patricia S Lorenzo
Journal:  Carcinogenesis       Date:  2014-01-24       Impact factor: 4.944

3.  Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity.

Authors:  Krzysztof Bryniarski; Wlodzimierz Ptak; Asha Jayakumar; Kerstin Püllmann; Michael J Caplan; Arthit Chairoungdua; Jun Lu; Brian D Adams; Emilia Sikora; Katarzyna Nazimek; Susanna Marquez; Steven H Kleinstein; Panjamaporn Sangwung; Yasuko Iwakiri; Eric Delgato; Frank Redegeld; Bart R Blokhuis; Jacek Wojcikowski; Anna Wladyslawa Daniel; Tom Groot Kormelink; Philip W Askenase
Journal:  J Allergy Clin Immunol       Date:  2013-05-31       Impact factor: 10.793

4.  Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules.

Authors:  Dan Ilkovitch; Laura K Ferris
Journal:  Mol Med Rep       Date:  2016-08-26       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.